| Title |
<em>Ginkgo biloba</em> extract in the treatment of tinnitus: a systematic review
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, July 2011
|
| DOI | 10.2147/ndt.s22793 |
| Pubmed ID | |
| Authors |
Alexander von Boetticher |
| Abstract |
Tinnitus is a symptom frequently encountered by ear, nose, and throat practitioners. A causal treatment is rarely possible, and drug and nondrug treatment options are limited. One of the frequently prescribed treatments is Ginkgo biloba extract. Therefore, randomized, placebo-controlled clinical trials of Ginkgo biloba extract preparations were searched for and reviewed systematically. There is evidence of efficacy for the standardized extract, EGb 761(®) (Dr Willmar Schwabe GmbH & Co KG Pharmaceuticals, Karlsruhe, Germany), in the treatment of tinnitus from three trials in patients in whom tinnitus was the primary complaint. Supportive evidence comes from a further five trials in patients with age-associated cognitive impairment or dementia in whom tinnitus was present as a concomitant symptom. As yet, the efficacy of other ginkgo preparations has not been proven, which does not necessarily indicate ineffectiveness, but may be due to flawed clinical trials. In conclusion, EGb 761(®), a standardized Ginkgo biloba extract, is an evidence-based treatment option in tinnitus. |
X Demographics
The data shown below were collected from the profiles of 70 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 18 | 26% |
| Germany | 4 | 6% |
| Australia | 2 | 3% |
| Peru | 1 | 1% |
| United Kingdom | 1 | 1% |
| Mexico | 1 | 1% |
| Venezuela, Bolivarian Republic of | 1 | 1% |
| Netherlands | 1 | 1% |
| Canada | 1 | 1% |
| Other | 0 | 0% |
| Unknown | 40 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 60 | 86% |
| Practitioners (doctors, other healthcare professionals) | 6 | 9% |
| Scientists | 4 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Iran, Islamic Republic of | 1 | <1% |
| United Kingdom | 1 | <1% |
| Turkey | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 106 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 23 | 21% |
| Researcher | 14 | 13% |
| Student > Master | 12 | 11% |
| Other | 9 | 8% |
| Student > Postgraduate | 8 | 7% |
| Other | 22 | 20% |
| Unknown | 22 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 33% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 13% |
| Agricultural and Biological Sciences | 13 | 12% |
| Nursing and Health Professions | 5 | 5% |
| Psychology | 5 | 5% |
| Other | 15 | 14% |
| Unknown | 22 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 276. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2024.
All research outputs
#132,950
of 25,853,983 outputs
Outputs from Neuropsychiatric Disease and Treatment
#17
of 3,152 outputs
Outputs of similar age
#402
of 129,396 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#1
of 12 outputs
Altmetric has tracked 25,853,983 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,152 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 129,396 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.